2021

1. Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients

   Annals of Hematology, Vol. 100, Núm. 4, pp. 1023-1029